Table 2

Molecular response rates to PEG-IFN-α-2a therapy

JAK2V617F allele burdenPV (n = 40) number (%)ET (n = 18) number (%)
CMR (undetectable) 7 (18) 3 (17) 
PMR (>50% decrease) 14 (35) 6 (33) 
mMR (20%-49% decrease) 3 (8) 3 (17) 
No response 16 (40) 6 (33) 
JAK2V617F allele burdenPV (n = 40) number (%)ET (n = 18) number (%)
CMR (undetectable) 7 (18) 3 (17) 
PMR (>50% decrease) 14 (35) 6 (33) 
mMR (20%-49% decrease) 3 (8) 3 (17) 
No response 16 (40) 6 (33) 
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal